Minerva Neurosciences NERV
NASDAQ NERV
$3.28 +0.05 (+1.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Return on Assets [ROA] (2014 - 2026)

Updated

Minerva Neurosciences' Return on Assets [ROA] came in at -35.20% for Q2 2026, up 13.26 percentage points from -48.46% a year earlier but down 7.65 percentage points from the prior quarter.

Analysis

Minerva Neurosciences (NERV) Return on Assets [ROA] (2014 - 2026) Analysis & Trends

For FY2025, Minerva Neurosciences' Return on Assets [ROA] was -20.95%, up 22.81 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of -23.83 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -43.76% in FY2024 (-5.04 pp), -38.72% in FY2023 (+9.85 pp), -48.57% in FY2022 (+25.50 pp) and -74.07% in FY2021 (-76.95 pp).
  • The five-year range for quarterly Return on Assets [ROA] is -66.19% (Q3 2022) to -22.46% (Q4 2025).
  • Year-over-year, Return on Assets [ROA] has increased for five consecutive quarters, with an average year-over-year change of +3.41 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q3 2023 (a gain of 36.03 percentage points), and the weakest in Q1 2022 (a drop of 69.88 percentage points).
  • Business Quant data shows NERV's Return on Assets [ROA] at -27.55% (Q1 2026), -22.46% (Q4 2025) and -47.86% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Minerva Neurosciences 154.91 Mn 154.91 Mn - -35.20%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -35.20%
Mar 31, 2026 -27.55%
Dec 31, 2025 -22.46%
Sep 30, 2025 -47.86%
Jun 30, 2025 -48.46%
Mar 31, 2025 -51.46%
Dec 31, 2024 -51.47%
Sep 30, 2024 -51.86%
Jun 30, 2024 -51.21%
Mar 31, 2024 -42.87%
Dec 31, 2023 -36.13%
Sep 30, 2023 -30.16%
Jun 30, 2023 -31.90%
Mar 31, 2023 -40.64%
Dec 31, 2022 -42.97%
Sep 30, 2022 -66.19%
Jun 30, 2022 -64.56%
Mar 31, 2022 -62.04%
Dec 31, 2021 -51.92%
Sep 30, 2021 -30.83%
API Access

Minerva Neurosciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NERV&period=max&api_key=YOUR_API_KEY